Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

02 Jun 2026 - 04 Jun 2026
17 Jun 2026 - 19 Jun 2026
05 Oct 2026 - 06 Oct 2026

Therapy for HIV Patients Failing Previous Therapy

By HospiMedica staff writers
Posted on 02 Oct 2000
In preclinical studies, the non-nucleoside reverse transcriptase inhibitor (NNRTI) capravirine demonstrated a potent antiviral activity against wild-type HIV as well as HIV strains with mutations in reverse transcriptase, such as K103N, that confer broad viral resistance to other NNRTIs to which patients failing treatment may have been exposed. More...


In clinical studies of treatment-naive patients, capravirine showed antiretroviral activity when used alone for a short period of time, and achieved target antiretroviral concentrations in plasma as a part of a combination therapy. A new double-blind 48-week study will evaluate capravirine for use in two groups of HIV-infected patients: those who have never been treated with anti-HIV medications and those who have failed previous treatment. Capravirine, which has been generally well tolerated by patients, was developed by Agouron Pharmaceuticals, Inc. (Toronto, Canada).



Related Links:
Agouron Pharmaceuticals

Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Blood Pressure Monitor
Cuff Blood Pressure Monitor
Gas Analyzer
GE SAM
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The Elyra TFL System uses thulium fiber laser technology for efficient stone dusting and reduced stone migration, with an air-cooled design for quieter, more compact operation (photo courtesy of BD

BD Launches Elyra Laser Platform for Kidney Stone and Soft Tissue Procedures

BD (Becton, Dickinson and Company) has introduced the Elyra Thulium Fiber Laser (TFL) System, an advanced laser platform developed to complete its kidney stone care portfolio for urology teams.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.